M&A

M&A deals among Irish life science firms soar 600% in value

Irish pharma firms took in $1.5 billion across seven deals last year, led higher by the sale of Cathal Friel’s Amryt Pharma

Fundraising activity within the industry also saw a notable increase in the year, with 12 Irish companies successfully raising growth capital totalling €142 million. Picture: Getty

The value of merger and acquisition (M&A) transactions within the Irish life sciences sector soared by almost 600 per cent to $1.5 billion (€1.375 billion) in 2023, led significantly higher by the sale of Amryt Pharma, the rare disease drug maker co-founded by Cathal Friel.

Fundraising activity within the industry also saw a notable increase in the year, with 12 Irish companies successfully raising growth capital totalling €142 million - highlighting global investors' continued interest ...